Timing of Antiretroviral Therapy in Cryptococcal Meningitis: What We Can (and Cannot) Learn From Observational Data
Clinical Infectious Diseases · 2023
DOI: 10.1093/cid/ciad123 ↗Kurz gefasst
Editorial in der Zeitschrift Clinical Infectious Diseases, 2023. Verfasst von David R Boulware und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, University of Minnesota, Minneapolis, Minnesota, USA. Hauptthemen laut MEDLINE: Meningitis, Cryptococcal, HIV Infections. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 21 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medicine, University of Minnesota, Minneapolis, Minnesota, USA.
- Department of Clinical Research, Faculty of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, London, United Kingdom.
ORCID-Profile: David R Boulware
Zitieren
APA
Boulware, D. R., & Jarvis, J. N. (2023). Timing of Antiretroviral Therapy in Cryptococcal Meningitis: What We Can (and Cannot) Learn From Observational Data. Clinical Infectious Diseases. https://doi.org/10.1093/cid/ciad123
Vancouver
Boulware DR, Jarvis JN. Timing of Antiretroviral Therapy in Cryptococcal Meningitis: What We Can (and Cannot) Learn From Observational Data. Clinical Infectious Diseases. 2023. doi:10.1093/cid/ciad123
BibTeX
@article{Boulware2023,
author = {Boulware, David R and Jarvis, Joseph N},
title = {Timing of Antiretroviral Therapy in Cryptococcal Meningitis: What We Can (and Cannot) Learn From Observational Data},
journal = {Clinical Infectious Diseases},
year = {2023},
doi = {10.1093/cid/ciad123}
}
EUVIMED